Stephens, R.S., Kalman, S., Lammel, C., Fan, J., Marathe, R., Aravind, L., Mitchell, W., Olinger, L., Tatusov, R.L., Zhao, Q., Koonin, E.V. and Davis, R.W. (1998) Genome Sequence of an Obligate Intracellular Pathogen of Humans. Chlamydia trachomatis. Science, 282, 754-759.
http://dx.doi.org/10.1126/science.282.5389.754

has been cited by the following article:

• TITLE: Screenning of Chlamydia trachomatis Infection among Women Attending Outpatient Clinic of Infertility

  AUTHORS: Heloisa Lopes Lavorato, Natália Prearo Moço, Laura Fernandes Martin, Ana Gabriela Pontes Santos, Anaglória Pontes, Marli Teresinha Cassamassimo Duarte, Márcia Guimarães da Silva

  KEYWORDS: Chlamydial Infection, Infertility, Molecular Diagnosis

  JOURNAL NAME: Open Journal of Obstetrics and Gynecology, Vol.5 No.11, September 18, 2015

  ABSTRACT: Objective: The goal of this study was to determine the prevalence of C. trachomatis in women diagnosed with infertility attending the Outpatient Clinic of Infertility from Botucatu Medical School, UNESP, Brazil. Patients and Methods: This molecular study enrolled a total of 112 women. Among these patients, 62 presented primary infertility while 50 presented secondary infertility. The criteria for eligibility included women who were: reproductive-aged; no prior report of seroconversion for HIV; no antibiotic or vaginal cream used in the preceding 30 days; and abstinence from sexual intercourse for 72 hours before the visit. The women were submitted to a gynecological examination and cervical samples were collected with an endocervical cytobrush for molecular analysis of C. trachomatis. Results: The prevalence of chlamydial infection was 8% with similar prevalence between primary (8.1%) and secondary (8.0%) infertility. Conclusion: Considering the asymptomatic nature of chlamydial infection and its association with tubal factor infertility, there is a pressing need to incorporate the screening of C. trachomatis infection as part of the routine investigation for infertility. The early diagnostic by screening can minimize complications and reduce Public Health costs with Assisted Reproductive Technology.